Factors Affecting Defining the Quality and Functionality of Excipients Used in the Manufacture of Dry Powder Inhaler Products

Author： Edge Stephen Mueller Stefan Price Robert Shur Jagdeep

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.34, Iss.9, 2008-09, pp. : 966-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parametric Two-Tier Sequential Quality Assurance Test of Delivery Dose Uniformity of Multiple-Dose Inhaler and Dry Powder Inhaler Drug Products

By Tsong Yi

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 5, 2008-09 ,pp. : 976-984

Taylor & Francis Ltd

Access to resources Recommend Favorite

Novolizer®: A Multidose Dry Powder Inhaler

By Fenton C. Keating G.M. Plosker G.L.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2437-2445

Adis International

Access to resources Recommend Favorite

The Effect of Relative Humidity on Electrostatic Charge Decay of Drugs and Excipient Used in Dry Powder Inhaler Formulation

By Elajnaf Abdulmajid Carter Paul Rowley Geoff

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 9, 2007-09 ,pp. : 967-974

Informa Healthcare

Access to resources Recommend Favorite

Novolizer® Multidose Dry Powder Inhaler: Profile Report

By Siddiqui M. Asif A. Plosker Greg L.

American Journal of Drug Delivery, Vol. 4, Iss. 1, 2006-01 ,pp. : 57-60

Adis International

Access to resources Recommend Favorite

Mometasone furoate dry powder inhaler for the treatment of asthma

By Fausnight Tracy B Craig Timothy J

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2707-2712

Informa Healthcare

Access to resources Recommend Favorite